New Japanese encephalitis vaccines: alternatives to production in mouse brain (Q34173039)

31 July 2017

1 reference

title

New Japanese encephalitis vaccines: alternatives to production in mouse brain (English)

1 reference

Japanese encephalitis virus

31 July 2017

0 references

Japanese encephalitis

1 reference

1 reference

1

Scott B Halstead

1 reference

31 July 2017

Stephen J Thomas

2

1 reference

31 July 2017

1 March 2011

1 reference

Expert Review of Vaccines

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

3

1 reference

31 July 2017

355-364

1 reference

Past, Present, and Future of Japanese Encephalitis

31 July 2017

1 reference

21 January 2018

Flavivirus encephalitis.

1 reference

A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader?

21 January 2018

1 reference

Japanese encephalitis in travelers from non-endemic countries, 1973-2008

21 January 2018

1 reference

A case of Japanese encephalitis

21 January 2018

1 reference

Fatal Japanese encephalitis in a Danish tourist visiting Bali for 12 days

21 January 2018

1 reference

Japanese encephalitis in travelers: review of cases and seasonal risk

21 January 2018

1 reference

Behavioural disturbances following Japanese B encephalitis

21 January 2018

1 reference

Japanese encephalitis in a swedish tourist after travelling to Java and Bali

21 January 2018

1 reference

Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand

21 January 2018

1 reference

Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants

21 January 2018

1 reference

Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis

21 January 2018

1 reference

Radiological and neurophysiological changes in Japanese encephalitis

21 January 2018

1 reference

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India

21 January 2018

1 reference

Clinical and immunological risk factors for severe disease in Japanese encephalitis

21 January 2018

1 reference

The effect of DDT spraying and bed nets impregnated with pyrethroid insecticide on the incidence of Japanese encephalitis virus infection

21 January 2018

1 reference

The protective effect of bed nets impregnated with pyrethroid insecticide and vaccination against Japanese encephalitis

21 January 2018

1 reference

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

21 January 2018

1 reference

Japanese encephalitis and vaccines: past and future prospects

21 January 2018

1 reference

Japanese encephalitis vaccine in travelers

21 January 2018

1 reference

Protection against Japanese encephalitis by inactivated vaccines

21 January 2018

1 reference

Current use and development of vaccines for Japanese encephalitis

21 January 2018

1 reference

Side-effects with Japanese encephalitis vaccine

21 January 2018

1 reference

Adverse reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

21 January 2018

1 reference

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

21 January 2018

1 reference

Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis

21 January 2018

1 reference

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

21 January 2018

1 reference

Control of Japanese encephalitis--within our grasp?

21 January 2018

1 reference

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

21 January 2018

1 reference

Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines

21 January 2018

1 reference

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

IC51 Japanese encephalitis vaccine

21 January 2018

1 reference

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

21 January 2018

1 reference

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

21 January 2018

1 reference

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

21 January 2018

1 reference

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study

21 January 2018

1 reference

Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up

21 January 2018

1 reference

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.

21 January 2018

1 reference

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.

21 January 2018

1 reference

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

21 January 2018

1 reference

Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.

21 January 2018

1 reference

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

21 January 2018

1 reference

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

21 January 2018

1 reference

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

21 January 2018

1 reference

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

21 January 2018

1 reference

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity

21 January 2018

1 reference

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults

21 January 2018

1 reference

Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland

21 January 2018

1 reference

Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.7

1 reference

31 July 2017

1 reference

PubMed ID

21434803